157 results on '"Spitzweg, Christine"'
Search Results
2. OR14-05 Taking Advantage Of The Interleukin-6-Biology In Differentiated Thyroid Cancer To Stimulate Sodium Iodide Symporter (NIS)-mediated Iodide Uptake In Engineered Mesenchymal Stem Cells
3. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice
4. NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
5. Gastroenteropancreatic Neuroendocrine Tumours
6. Supplementary Data FS1 from Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice
7. Supplementary Data FS1 from Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice
8. Supplementary Figure S2 from Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
9. Supplementary Figure S1 from Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
10. Supplementary Figure S2 from Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
11. Supplementary Figure S1 from Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
12. Thyroidal Angiotensin-Converting Enzyme 2 Protein Expression and Thyroid Function Tests in Patients with COVID-19: Results from a Retrospective Case Series and a Prospective Cohort Study
13. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
14. Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice
15. Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
16. Patient-reported outcomes (PROS) from patients with RET-mutant medullary thyroid cancer (MTC) and ret fusion-positive TC treated with pralsetinib in the arrow trial
17. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study
18. Medulläres Schilddrüsenkarzinom
19. Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis
20. Molekular zielgerichtete Therapien beim radiojodrefraktären differenzierten Schilddrüsenkarzinom – Update 2022
21. Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board
22. Preoperative Imaging with [18F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
23. The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
24. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
25. Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes
26. Medikamentöse Systemtherapie bei Neuroendokrinen Neoplasien des GastroEnteropankreatischen Systems
27. Medulläres Schilddrüsenkarzinom
28. Medulläres Schilddrüsenkarzinom
29. Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma
30. Update zur Hypothyreose
31. Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer
32. FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
33. Taking Advantage of the TGFB1 Biology in Differentiated Thyroid Cancer to Stimulate Sodium Iodide Symporter (NIS)-Mediated Iodide Uptake in Engineered Mesenchymal Stem Cells
34. Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours
35. An unusual case of struma ovarii
36. The diagnostic challenge of coexistent sarcoidosis and thyroid cancer – a retrospective study
37. Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy
38. 18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
39. Radiation to the Primary Tumor in Metastatic Anaplastic Thyroid Cancer
40. Integrin αvβ3-dependent thyroid hormone effects on tumour proliferation and vascularisation
41. Therapeutic Potential of Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene Delivery in Liver Cancer
42. Liver Detargeting of Adenoviral Vectors by Polymer Coating after Systemic Delivery Using the Sodium Iodide Symporter (NIS) as Reporter Gene
43. The Sodium–Iodide Symporter (NIS)
44. Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients
45. Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor
46. Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients
47. Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis
48. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
49. Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma
50. Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.